Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Rixa Health
CoreAge Rx and Rixa Health both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxRixa Health
Ranked #174 · Grade C
Best for: A parent who will cost the whole ladder before starting, and wants every step priced in advance.
Visit Rixa HealthThe verdict
CoreAge Rx edges out Rixa Health on the Rx-Readiness Score, 95 to 56 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Rixa Health is still a genuine option — cost this at the dose you will end up on, not the one you start at. Tirzepatide runs $280 per four weeks at 2.5 mg and $525 at 15 mg — thirteen cycles a year, so $3,640 against $6,825. Semaglutide is stranger: two of its five levels cover five weeks rather than four, which makes level three cheaper per week than level two despite the higher dose, and contradicts the sentence directly above the table. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Rixa Health |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 56/100 · C |
| Overall rank | #1 | #174 |
| Semaglutide | $99/mo | $195 per 4 weeks at the lowest dose, rising to $310 |
| Tirzepatide | $149/mo | $280 per 4 weeks at the lowest dose, rising to $525 |
| Coverage | All 50 states | Published per provider, not site-wide; one is listed for Michigan and Ohio |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Rixa Health
Ranked #174 · Grade C
What we like
- Publishes every level with its milligrams and its price — five for semaglutide, six for tirzepatide
- States that the price covers medication, shipping and provider contact between refills
- No contracts or long-term commitments; HSA and FSA accepted
The caveats
- Tirzepatide nearly doubles across the ladder — $3,640 to $6,825 a year at thirteen cycles
- The billing period changes mid-ladder, so cost per week is not monotonic
- The line above the table promises four-week pricing and two of its five rows are five-week
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Rixa Health against other providers on our shortlist.
Or browse the full comparison hub.